diroximel fumarate,alks 8700
biogen
['ease', 'evolve-ms-1', 'evolve,ms-1', 'biogen']
new data at ectrims 2022 highlight biogen s commitment to advancing individualized disease management for people living with ms - safety and efficacy results from the phase 3 evolve-ms-1 trial demonstrate decreases in disease activity and favorable tole... 
CEO Of Digital Media Online